Nine Masts Capital’s Tenaya Therapeutics TNYA Stock Holding History

Nine Masts Capital’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,344	Closed	-$35.6K	–	291
2026 Q1	$35.6K	Buy	+51,344	New	+$37.9K	0.01%	197

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nine Masts Capital's TNYA Position: Q2 2026 in Review

Nine Masts Capital sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 51,344 shares — an estimated $35.6K sold.

Nine Masts Capital first reported a position in TNYA in Q1 2026 and held it in 1 quarter. The position peaked at $35.6K in Q1 2026. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Nine Masts Capital reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 51,344 Tenaya Therapeutics shares in Q2 2026, an estimated $35.6K.
Nine Masts Capital first reported a position in Tenaya Therapeutics in Q1 2026 and held it in 1 quarter.
Nine Masts Capital's Tenaya Therapeutics position peaked at $35.6K in Q1 2026.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.